The Investor Relations website contains information about Progenics Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.
http://ir.progenics.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
0.3 seconds
16x16
PAGES IN
THIS WEBSITE
17
SSL
EXTERNAL LINKS
92
SITE IP
23.213.123.49
LOAD TIME
0.268 sec
SCORE
6.2
Investor Relations | Progenics Pharmaceuticals, Inc. | ir.progenics.com Reviews
https://ir.progenics.com
The Investor Relations website contains information about Progenics Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.
ir.progenics.com
SEC Filings - Progenics Pharmaceuticals, Inc.
http://ir.progenics.com/sec.cfm
PSMA Targeted Imaging Compound (1404) Technology. PSMA ADC Therapeutic Technology. Small Molecule Therapeutic Technology. Progenics In The News. 4:00 PM ET on August 26. Aug 25, 2016. Aug 4, 2016. Aug 4, 2016. Jul 20, 2016. Jun 9, 2016. Scheinberg, david a. Jun 9, 2016. Crowley, peter j. Jun 9, 2016. Campbell, bradley l. Jun 9, 2016. Ferrante, karen jean. Jun 9, 2016. Kishbauch, michael d. Jun 9, 2016. Jun 9, 2016. Jun 8, 2016. May 10, 2016. Definitive additional proxy materials. May 5, 2016. May 5, 2016.
Events & Presentations - Progenics Pharmaceuticals, Inc.
http://ir.progenics.com/events.cfm
PSMA Targeted Imaging Compound (1404) Technology. PSMA ADC Therapeutic Technology. Small Molecule Therapeutic Technology. Progenics In The News. Progenics In The News. 4:00 PM ET on August 26. Details on upcoming events are not yet available. Aug 4, 2016. Progenics Pharmaceuticals Second Quarter 2016 Results Conference Call. Jul 13, 2016. Cantor Fitzgerald's 2nd Annual Healthcare Conference Webcast. Jun 9, 2016. Jefferies 2015 Healthcare Conference. May 5, 2016. Apr 13, 2016. Mar 16, 2016. Mar 11, 2016.
Historic Stock Lookup - Progenics Pharmaceuticals, Inc.
http://ir.progenics.com/stocklookup.cfm
PSMA Targeted Imaging Compound (1404) Technology. PSMA ADC Therapeutic Technology. Small Molecule Therapeutic Technology. Progenics In The News. 4:00 PM ET on August 26. Week of August 22, 2016. Aug 22, 2016. Aug 23, 2016. Aug 24, 2016. Aug 25, 2016. Aug 26, 2016. Year End Stock Prices.
Quarterly Results - Progenics Pharmaceuticals, Inc.
http://ir.progenics.com/results.cfm
PSMA Targeted Imaging Compound (1404) Technology. PSMA ADC Therapeutic Technology. Small Molecule Therapeutic Technology. Progenics In The News. 4:00 PM ET on August 26. Progenics Pharmaceuticals Announces Second Quarter 2016 Financial and Business Results. Progenics Pharmaceuticals Announces First Quarter 2016 Financial and Business Results. Progenics Pharmaceuticals Announces Fourth Quarter and Full-Year 2015 Financial and Business Results. Progenics Pharmaceuticals Announces Fourth Quarter and Year-En...
Investor FAQs - Progenics Pharmaceuticals, Inc.
http://ir.progenics.com/faq.cfm
PSMA Targeted Imaging Compound (1404) Technology. PSMA ADC Therapeutic Technology. Small Molecule Therapeutic Technology. Progenics In The News. 4:00 PM ET on August 26. Under what symbol and on what exchange does Progenics Pharmaceuticals trade? Progenics trades under the symbol PGNX on the Nasdaq Stock Exchange. When was Progenics founded? Who is the transfer agent for Progenics Pharmaceuticals, Inc? American Stock Transfer and Trust Company. New York, NY 10005. Type in number *.
TOTAL PAGES IN THIS WEBSITE
17
Clinical Trials Overview
http://www.progenics.com/clinical-trials
1404 PSMA Targeted Imaging. PyL – PSMA Targeted PET Imaging Agent. 1095 – Small Molecule Therapeutic. Azedra – Ultra-Orphan Radiotherapeutic. Progenics In The News. Targeting & Treating Cancer. Progenics is committed to improving patient care through the detection, treatment, and management of cancer. Prospective patients or their physicians who may be interested in participating in these clinical trials may wish to refer to information on these pages or contact the clinical department.
Become A Partner - Progenics
http://www.progenics.com/business-development/become-a-partner
1404 PSMA Targeted Imaging. PyL – PSMA Targeted PET Imaging Agent. 1095 – Small Molecule Therapeutic. Azedra – Ultra-Orphan Radiotherapeutic. Progenics In The News. See our full product pipeline for more information. To learn more about Progenics’ ongoing business development efforts, please complete the form below.
Business Development Overview
http://www.progenics.com/business-development/overview
1404 PSMA Targeted Imaging. PyL – PSMA Targeted PET Imaging Agent. 1095 – Small Molecule Therapeutic. Azedra – Ultra-Orphan Radiotherapeutic. Progenics In The News. Progenics evaluates opportunities to expand our focused oncology pipeline on an on-going basis, including in- and out-licensing arrangements and product and company acquisitions. Upon approval of product candidates we expect to commercialize some directly and explore marketing partnerships for others. HIV Viral Entry Inhibitor.
Clinical Trials Overview
http://www.progenics.com/clinical-trials/overview
1404 PSMA Targeted Imaging. PyL – PSMA Targeted PET Imaging Agent. 1095 – Small Molecule Therapeutic. Azedra – Ultra-Orphan Radiotherapeutic. Progenics In The News. Targeting & Treating Cancer. Progenics is committed to improving patient care through the detection, treatment, and management of cancer. Prospective patients or their physicians who may be interested in participating in these clinical trials may wish to refer to information on these pages or contact the clinical department.
Progenics In The News - Progenics
http://www.progenics.com/media-center/in_the_news
1404 PSMA Targeted Imaging. PyL – PSMA Targeted PET Imaging Agent. 1095 – Small Molecule Therapeutic. Azedra – Ultra-Orphan Radiotherapeutic. Progenics In The News. Progenics In The News. In the News…. Bioworld Today Azedra Article. European Journal of Nuclear Medicine and Molecular Imaging: Compassionate Use Study of MIP 1095 in Men with Prostate Cancer. Not in conjuction with a clinical trial). Nicholas Vogelzang, MD, medical oncologist on PSMA ADC for prostate cancer.
Azedra
http://www.progenics.com/product-pipeline/azedra
1404 PSMA Targeted Imaging. PyL – PSMA Targeted PET Imaging Agent. 1095 – Small Molecule Therapeutic. Azedra – Ultra-Orphan Radiotherapeutic. Progenics In The News. 1404 PSMA Targeted Imaging. PyL – PSMA Targeted PET Imaging Agent. 1095 – Small Molecule Therapeutic. Azedra – Ultra-Orphan Radiotherapeutic. See our full product pipeline for more information. Get more information on our current trials. With a much lower specific activity and less desirable side effect profile has been used with some success...
CEO Videos - Progenics
http://www.progenics.com/media-center/videos
1404 PSMA Targeted Imaging. PyL – PSMA Targeted PET Imaging Agent. 1095 – Small Molecule Therapeutic. Azedra – Ultra-Orphan Radiotherapeutic. Progenics In The News. Progenics In The News. Videos from Progenics’ CEO, Mark R. Baker. Molecular Imaging Agents (1404). Mark on Visualizing prostate cancer using MIP 1404, Progenics Imaging Candidate. Mark on… Diversifying Progenics pipeline to maximize potential and minimize risk. How PSMA ADC Functions.
Business Development Overview
http://www.progenics.com/business-development
1404 PSMA Targeted Imaging. PyL – PSMA Targeted PET Imaging Agent. 1095 – Small Molecule Therapeutic. Azedra – Ultra-Orphan Radiotherapeutic. Progenics In The News. Progenics evaluates opportunities to expand our focused oncology pipeline on an on-going basis, including in- and out-licensing arrangements and product and company acquisitions. Upon approval of product candidates we expect to commercialize some directly and explore marketing partnerships for others. HIV Viral Entry Inhibitor.
Management Team - Progenics
http://www.progenics.com/about-us/management-team
1404 PSMA Targeted Imaging. PyL – PSMA Targeted PET Imaging Agent. 1095 – Small Molecule Therapeutic. Azedra – Ultra-Orphan Radiotherapeutic. Progenics In The News. The drug development process is complex. Our management team offers deep expertise in all aspects of the process to drive products toward commercialization. Mark R. Baker. Senior Vice President and Chief Financial Officer. Executive Vice President and General Counsel. Vivien Wong Ph.D. Executive Vice President, Development.
TOTAL LINKS TO THIS WEBSITE
92
Investors - PRA Group
Core Acquisitions and Collections. Stock Split and Dividend. PRA In the News. Stock Split and Dividend. 4:00 PM ET on Aug 17, 2015. Delayed 20 min. By eSignal. PRA has been recognized as one of Fortunes 100 Fastest-Growing Companies for the past three years and one of Forbes Best Small Companies in America for eight consecutive years since 2007. Aug 10, 2015. PRA Group Reports Second Quarter 2015 Results. Aug 10, 2015. PRA Group Appoints Kevin Stevenson as President. View all press releases ».
Corporate Profile - Prestige Brands Inc. | Prestige Brands
Eye, Ear, Nose and Throat. Q1 2016 Prestige Brands Holdings Inc. Earnings Conference Call. 160;at 8:30 am ET. Prestige Brands Holdings, Inc. 160; 0.35. Prestige Brands, Inc. markets, sells and distributes over-the-counter healthcare and household cleaning products to retail outlets in the US, Canada, and certain international markets. Prestige Brands offices are located in Tarrytown, NY and Jackson, WY. View Our Annual Reports. Aug 06, 2015. Jul 13, 2015. Jun 24, 2015. It's Time for TMI: When It Comes To...
Digital camera Digital Cameras - Cameras - Imaging Resource - Shopping Comparison - Smart Shopping Anytime, Anywhere
Lens Reviews on SLR Gear. New on the site. Reviews by SLR Gear Readers. Leonisa Brief Panty Compression. As Seen On Tv. Vacuum and Steam Cleaners. Outdoor Barbecue Grills and Smokers. Mechanics Tools and Tool Sets. Motorcycle Parts and Accessories. Shop Babies and Kids. Baby, Toddler and Kids Bedding. Baby Convertible Car Seats. Baby Swings and Bouncers. Camera and Camcorder Lenses. Photo Batteries and Chargers. Camera Bags and Cases. Camera Hotshoe Flashes and Ringlights. Men's Jackets and Coats. Coffee...
Overview - The Priceline Group
The Priceline Group is the world’s leading provider of online travel and related services, provided to consumers and local partners in over 200 countries through six primary brands: Booking.com, priceline.com, KAYAK, agoda.com, rentalcars.com, and OpenTable. 081415 4:00 PM EST Delayed at least 20min., by eSignal. Q2 2015 The Priceline Group Earnings Conference Call. 080515 7:30 AM ET. Q1 2015 The Priceline Group Earnings Conference Call. 050715 7:30 AM ET. View all events and presentations ».
Investor Relations - Primo Water Corporation
Report or Notice of. Day High: 11.79. Day Low: 11.64. 4:00 PM ET on Mar 29, 2018. Delayed at least 20 minutes. Primo Water Corporation (Nasdaq:PRMW) is a leading provider of multi-gallon purified bottled water, self-service refill water and water dispensers sold through major retailers throughout the United States and Canada. Mar 6, 2018. Primo Water Announces Fourth Quarter and Full Year 2017 Financial Results. Feb 13, 2018. Mar 6, 2018 at 4:30 PM ET. Primo Water Fourth Quarter 2017 Financial Results.
Investor Relations | Progenics Pharmaceuticals, Inc.
Skip to main navigation. PSMA Targeted Imaging Compound (1404) Technology. PSMA ADC Therapeutic Technology. Small Molecule Therapeutic Technology. Progenics In The News. 11:33 PM EDT on Mar 29. Progenics Investor relations Team works to provide, shareholders, analysts and potential investors with timely, relevant and reliable information. Mar 22, 2018. Progenics Pharmaceuticals Announces Three-Month Extension of PDUFA Date for AZEDRA (iobenguane I 131). Mar 20, 2018. Legal and Usage Terms.
Investor Relations
Enter your username and password here in order to log in on the investor website:. Create a new investor login. Access to the restricted area is only available to authorized personnel. If you are already an investor or are interested in our bond, please register via the contact form below. الإمارات العربي ة المت حدة. South Georgia and the South Sandwich Islands. British Indian Ocean Territory. العراق / عي راق. Saint Kitts and Nevis. ශ ර ල ක / இலங க. New Zealand / Aotearoa. Papua New Guinea / Papua Niugini.
Prologis
Skip to main content. Stock Quote and Chart. Fixed Income and Corporate Ratings. Stock Quote and Chart. Fixed Income and Corporate Ratings. Annual Net Operating Income. Most Sustainable Companies Globally. Q4 2017 Supplemental Financial Report (PDF). Q1 2018 FINANCIAL RESULT WEBCAST AND CONFERENCE CALL. Prologis to Announce First Quarter 2018 Results April 17. Subscribe to get the latest investor news and information delivered directly to your inbox.
Investor Relations :: Propanc Health Group Corporation (PPCH)
Ended June 30, 2016. Research and development YTD. Net cash used in operations YTD. Jan 11, 2017. Propanc Receives Allowance of Key Patent Application for Method of Treating Solid Tumors in the US. Ended Sep 30, 2016. Sign Up For E-Mail Alerts. View Detailed Stock Info. Propanc Health Group Corporation. View Board of Directors. New York, NY 10022. Corporate Stock Transfer Inc. 3200 Cherry Creek South Drive. Denver, CO 80209. 2016 Propanc Health Group Corporation.
Overview :: Protalex, Inc. (PRTX)
Protalex, Inc. on LinkedIn. Protalex, Inc. on Facebook. Protalex, Inc. on Twitter. Protalex, Inc. on Google Plus. Patents and Intellectual Property. Sign up for email alerts. Be the first to receive breaking news. Protalex Receives Positive Interim Review from Independent Safety Monitoring Committee in Its European Phase 1b Study of PRTX-100 to Treat Immune Thrombocytopenia. May 2, 2016. Nov 30, 2016. Officers & Directors. Arnold P. Kling. Kirk M. Warshaw. Chief Financial Officer, Secretary and Director.
SOCIAL ENGAGEMENT